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Summary 
Major hlstocompatlblllty complex (MHC) class 
I-restricted cytotoxlc T lymphocytes (CTL) recognize 
peptlde epltopes of protein antigens In a hierarchical 
fashion. We Investigated whether proteolytlc cleav- 
age, in particular by proteasomes, Is Important in de- 
termlnlng epitope hierarchy. Using highly purified 20s 
proteasomes, we find preferred cleavage sites directly 
adjacent to the N- and C-terminal ends of the Immuno- 
dominant epltope of chicken ovalbumln, Ova257-264, 
while most of the subdominant epltope, Ova55-62, is 
destroyed by a major cleavage site located within this 
epltope. Moreover, we show that variations In amino 
acid sequences flanking these epltopes influence pro- 
teasomal cleavage patterns In parallel with the efficacy 
of their presentation. The results suggest that protea- 
somal cleavage within and adjacent to class I-restricted 
epltopes contrlbutes to their level of presentation. 
Introduction 
Major histocompatibility complex (MHC) class I molecules 
present peptide epitopes, mainly derived from cytosolic 
and nuclear proteins, for recognition by CD6’ cytotoxic T 
lymphocytes (CTLs). These peptides are usually 6-l 1 aa 
in length and most of them contain a MHC allele-specific 
consensus motif (Falk et al., 1991; Falk and Rotzschke, 
1993). The number of peptides within an antigenic protein 
that can bind to a particular class I molecule is usually 
considerably larger than the number of epitopes recog- 
nized in a CTL response to that protein. Moreover, re- 
sponses to different epitopes may differ dramatically in 
strength. Often, only a single immunodominant epitope 
out of a number of potential epitopes is recognized, such 
as in the Kb- and Db-restricted CTL response against the 
Gag and Env proteins of the mink cell focus-inducing mu- 
rine leukemia virus (Sijts et al., 1994) or in the Kd-restricted 
CTL response against Listeria monocytogenes listerio- 
lysin 0 (Pamer et al., 1991). There is growing evidence 
that a number of epitopes are silent under physiological 
conditions because they are presented at a density too 
lowto induce CTL(Sheil et al., 1992; Feltkampet al., 1993; 
Houbiers et al., 1993; Sadovnikova et al., 1994; Oukka et 
al., 1994). 
The level of presentation therefore appears to be one 
of the parameters, in addition to the repertoire of the re- 
sponding CTL, that determine the immunogenicity of an 
epitope. The availability of peptides for assembly of MHC 
class I-peptide complexes in the endoplasmic reticulum 
(ER), as well as their binding affinities, are factors influenc- 
ing the presentation level. The class l-binding affinities 
described so far for immunodominant epitopes are usually 
very high (Jameson and Bevan, 1992; Lipford et al., 1993; 
Sijts et al., 1994). However, not all strongly binding pep- 
tides are immunodominant epitopes (Wipke et al., 1993). 
The availability of peptides for assembly depends on the 
peptide import to the ER by the transporters associated 
with antigen presentation (TAP), as well as on proteolytic 
antigen processing. The transporters select peptides ac- 
cording to size and some sequence characteristics (Shep- 
herd et al., 1993; Heemels et al., 1993; Momburg et al., 
1994a, 1994b; Schumacher et al., 1994; Androlewicz and 
Cresswell, 1994). However, selectivity at the level of trans- 
port has so far not been related to epitope hierarchy. 
Class l-restricted epitopes are generated by limited pro- 
teolysis involving endoproteases and perhaps trimming 
exopeptidases. Proteasomes have been suggested to be 
the major enzymatic component for the processing of cyto- 
solic and nuclear antigens (for review see Goldberg and 
Rock, 1992; Monaco, 1992; Howard and Seelig, 1993). 
The 20s proteasome is a ubiquitous -700 kDa multisub- 
unit proteolytic complex located in the cytosol and in the 
nucleus. As a catalytic core of the larger 26s proteasome 
and perhaps in the 20s form as well, it is involved in ubiqui- 
tin-dependent and ubiquitin-independent protein degrada- 
tion pathways (for review see Goldberg, 1992). Evidence 
indicating a role for proteasomes in antigen processing 
has previously been presented. More efficient antigen pre- 
sentation was achieved by modification of an antigen that 
led to its faster degradation in the ubiquitin-dependent 
pathway (Townsend et al., 1966); a cell line expressing 
a temperature-sensitive mutant of the ubiquitin-activating 
enzyme presented antigen only at permissive temperature 
(Michalek et al., 1993). A set of peptide aldehydes were 
shown to inhibit antigen presentation in vivo at concentra- 
tions inhibiting proteasome activity in vitro (Rock et al., 
1994). Two polymorphic proteasome subunits are en- 
coded in the class II region of the MHC complex linked 
to the TAP genes (Brown et al., 1991; Ortiz-Navarrete et 
al., 1991; Glynne etal., 1991; Martinezand Monaco, 1991; 
Kelly et al., 1991). These MHC-encoded proteasome sub- 
units are not essential for stable class I molecule surface 
expression and presentation of certain viral epitopes (Ar- 
nold et al., 1992; Momburg et al., 1992; Yewdell et al., 
1994; Zhou et al., 1994), but may modulate the fine speci- 
ficity of peptide processing by proteasomes (Driscoll et 
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Figure 1. Localization by Confocal Microscopy of Liposome-Entrapped FITC-dextran (average 20 kDa) in Macrophages 
(A) Vesicular fluorescence resulting from incubation of macrophages with pH-insensitive liposomes. 
(8) Diffuse fluorescence of FITC-dextran released into the cytoplasm from pH-sensitive liposomes. The images show single optical sections at 
approximately half the distance between apical and basal poles of the cells. Details of liposome-cell incubations and fluorescence-microscopic 
conditions are described in Experimental Procedures. Scale bar, 5 urn. 
al., 1993; Gaczynska et al., 1993; Boes et al., 1994). Defi- 
ciencies in the presentation of certain antigens have been 
observed in mice carrying targeted mutations of the LMP 
genes (Van Kaer et al.,1 994; Fehling et al., 1994). Further- 
more, the basic catalytic properties of proteasomes (Car- 
dozo et al., 1992; Orlowski et al., 1993) are consistent with 
the hydrophobic or basic amino acids at the carboxyl ends 
of most peptides eluted from class I molecules (for review 
see Elliott et al., 1993; Engelhard, 1994). Recently, it has 
been shown for two proteins that 20s proteasomes are 
able to generate antigenic peptides without the participa- 
tion of other proteases (Dick et al., 1994). 
Here, we investigated the role of proteolytic processing 
by proteasomes in determining hierarchies among MHC 
class I epitopes of protein antigens. We compared pro- 
cessing and presentation of a novel subdominant epitope 
of ovalbumin (Ova), Ova%-62 (Chen et al., 1994) with 
the known immunodominant epitope, Ova257-264 (Rbtz- 
schke et al., 1991). Synthetic 22-mer peptides containing 
these epitopes within natural and artificial flanking regions 
were introduced into the cytosol of target cells with the 
help of pH-sensitive liposomes. The efficiency of presenta- 
tion of the epitopes was determined in a CTL assay. More- 
over, these 22-mer peptides were digested with isolated 
20s proteasomes and proteasome cleavage sites were 
determined. The data show that the patterns of proteaso- 
mal cleavage within and adjacent to potential epitopes 
correlate with the efficiency of target cell recognition by 
epitope-specific CTL and hence with their immunoge- 
nicity. 
Results 
Liposomal Transfer of Peptide Antigens 
into the Class I Presentation Pathway 
We used pH-sensitive liposomes, which have been shown 
to be convenient vehicles for introducing protein antigens 
into the class I pathway of antigen processing (Harding 
et al., 1991; Reddyet al., 1991). Among various potential 
target cells, we found that some macrophage cell lines 
(P366, IC-21), as well as primary bone marrow-derived 
macrophages, efficiently internalize liposomes. pKsensi- 
tive liposomes composed of dioleoyl succinylglycerol and 
dioleoyl phosphatidylethanol-amine (DOSG-DOPE) re- 
leased encapsulated fluorescein isothiocyanate (FITC)- 
dextran efficiently into the cytosol of IC-21 macrophages, 
whereas the same material introduced into the cells by 
pH-insensitive liposomes remained associated with the 
endosomalllysosomal compartment (Figure 1). To prevent 
exogenous sensitization by peptides leaking from lipo- 
somes, target cells were loaded with liposome-encapsu- 
lated peptides in the presence of the free competitor pep- 
tide 04-TNP (Ova257-264 substituted at position 4 with 
trinitrophenyl-lysine; Martin et al., 1993). This peptide 
binds with high affinity to the Kb molecule, but is not recog- 
nized by the CTL clone 4G3 specific for Ova257-264. 
When IC-21 target cells were loaded, in the presence of 
this competitor peptide, with liposomes containing oval- 
bumin or the synthetic 22-mer Ova-Y249-269, they were 
efficiently lysed by the CTL clone 4G3. Lysis was com- 
pletely inhibited by brefeldin A (data not shown), which 
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Table 1. Amino Acid Sequences of Synthetic 22mer Peptides Used 
in this Study’ 
Peptide Sequence 
POval (Ova-Y249-269)b YVSGLEQLESIINFEKLTEWTS 
PoVa2 YGSGGGQGGSIINFEKLmTS -- 
POva3 YGSGGGQGGSIINFEKLTEWTS -- 
POva4 YVSGLEQLESIINFEKLPEWTS 
POva-Y47-67 YDSTRTQINKWRFMLPGFGD 
POva-Y51-7td YTQINKWRFDKLPGFGDSIEA 
PCrypl YDSTRTQINSIINFEKLPGFGD 
Pclyp2 YVSGLEQLEKWRFDKLTEWTS 
’ The single-letter amino acid code is used. b.c,d Peptides according 
to chicken ovalbumin amino acid sequences 249-26gb), 47-67E), and 
51-716) preceded by a tyrosine residue. The other peptides contain 
either the immunodominant p-restricted epitope Ova257-264 or the 
subdominant epitope Ova55-62 and have modified flanking amino 
acid sequences. Epitopes in bold; flanking regions in lower case. All 
peptides contained an additional tyrosine to facilitate the protein deter- 
mination by the Lowry method. Amino acid substitutions in flanking 
regions between Ova-Y249-269 and peptides POva2-4 are under- 
lined. Pcrypl and PcrypP contain either the immunodominant or the 
subdominant ovalbumin epitope and the flanking regions of the oppo- 
site epitope. 
blocks the presentation of peptides loaded onto class I 
molecules in the ER without affecting presentation of exo- 
geneously added peptides (Nuchtern et al., 1989; Yewdell 
and Bennink, 1989). Thus, lysis of liposome-pulsed target 
cells in the presence of competitor peptide represents tar- 
get cell sensitization by endogeneous antigen processing. 
Influence of Attiflcial Flanking Regions on the 
Presentation of the Immunodomlnant Kb-Restricted 
Ovalbumin Epitope 0~257-264 
We analyzed a synthetic 22-mer corresponding to the 
chicken Ova sequence 249-289 (POval), containing the 
immunodominant Kb-restricted epitope Ova257-284 in its 
center. In addition, we designed 22-mer peptides (POvaP, 
POva3, POva4) in which the flanking regions were substi- 
tuted in such a way that impaired proteolytic cleavage 
by proteasomes was to be expected (Table 1). Besides a 
trypsin-like activity cleaving after basic amino acids, pro- 
teasomes efficiently cleave peptide bonds on the carboxyl 
side of hydrophobic and of acidic amino acid residues 
(Cardozo et al., 1992; Orlowski et al., 1993) which are 
both frequent in the flanking regions of Ova257-284. To 
generate POva2, such amino acids were substituted by 
Gly residues. In addition, the Thr flanking the C terminus 
of the epitope was replaced by a Pro, thereby generating 
a peptide bond that includes a secondary amine and that is 
usually relatively resistent to endoproteases with broader 
substrate specificity (Demuth et al., 1993). POva3 con- 
tained the artificial N-terminal flanking region of POva2 
and the natural C-terminal flanking region. POva4 con- 
tained both natural flanking regions with the exception of 
the Pro replacement flanking the C terminusof theepitope. 
The titration data in Figure 2A show that lysis of target 
cells loaded with POva2 is significantly reduced as com- 
pared with target cells loaded with POval. The lysis of 
target cells loaded with POva3 and POva4 is intermediate 
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Figure 2. Effect of Artificial Flanking Regionson Antigen Presentation 
from Synthetic 22-mer Peptides Delivered into IC-21 Macrophages by 
pH-Sensitive Liposomes 
IC-21 macrophages (1.5 x 109 coincubated with the competitor pep- 
tide 04TNP were pulsed with either empty liposomes (open squares) 
or various liposome-encapsulated peptides. 
(A) shows POval at 4 ug (large closed squares), at 2 ug (medium-sized 
closed squares), or at 1 pg (small closed squares); POva2 at 4 ug 
(large closed triangle), at 2 ug (medium-sized closed triangle), or at 
1 ug (small closed triangle). 
(6) shows 2 ug of POval (closed square), POva2 (closed triangle), 
POvd (open circle), or POva4 (closed circle) as described in Experi- 
mental Procedures. 5’Cr-labeled macrophages were then tested for 
specific lysis by CTL clone 4G3 in a 4 hr %r release assay. The amino 
acid sequences of the peptides used are given in Table 1. (A) and (S) 
show independent representative experiments. 
between that of target cells loaded with POva2 and POval 
(Figure 2B), which was also ascertained by titrations (data 
not shown). The results suggest that flanking sequences 
are of importance in the generation of class I epitopes. 
Sequences flanking both the N- and C-terminal ends of 
an epitope appear to exert roughly additive influences. 
However, even though the amino acid replacements in the 
flanking regions were chosen to compromise proteasomal 
cleavage, these effects may be exerted at any level of 
processing, including digestion by other proteases in the 
cytosol or ER, peptide transport, or binding to class I mole- 
cules. 
Subdominance of the Epitope Ova55-62 
As previously reported (Jameson and Bevan, 1992; Lip- 
ford et al., 1993) Ova%-82 has the correctly spaced an- 
chor residues for the Kb molecule (Falk et al., 1991). The 
Kb binding affinity of this epitope was reported to be 5 to 
lo-fold (Jameson and Bevan, 1992; Lipford et al., 1993) 
or about 50-fold (Chen et al.,1994) lower than that of the 
immunodominant epitope Ova257-284. CTLs specific for 
Ova55-82 have not been found upon immunization of 
C57BU8 mice with Ova or with a syngeneic cell line 
transfected with the ovalbumin gene (EG7) (Moore et al., 
1988; Lipford et al., 1993; data not shown). Chen et al. 
(1994) induced Ova55-82-specific CTL with stimulator 
cells loaded by electroporation with excessive concentra- 
tions of Ova, and showed that the primed CTL precursor 
frequencies were similar to that for Ova257-284. We gen- 
erated CTL specific for Ova55-82 by in vitro incubation 
Immunity 
292 
A 
80. 
80. 
8o:l 8.7 : 1 0.7 : 1 
807 
60 
I\ 
Stim. cells x 1O.OOO/well 
D 
!L 
I:1 3:l a3:l 
EffectorlTarget Ratio 
3o:l 3:l 0.3:1 
EffectodTarget Ratio 
Figure 3. The Epitope Ova55-62 Is Processed and Presented by EG7 
Cells in Amounts Sufficient for CTL Recognition and Restimulation 
(A) Lysis of various target cells by Ova55-62~specific peptide-induced 
CTL: EL4 cells pulsed with homologous peptide (large closed squares), 
EL4 cells mock pulsed (small closed squares), EL-4 cells transfected 
with the chicken ovalbumin cDNA (EG7 cells) (closed circles), and 
EG7 cells pretreated with 250 U/ml IFNy (open circles). 
(6) Lysis of various target cells by CTL clone 4G3, same symbols as 
in (A). 
(C) Lysis of IC-21 macrophages by Ova55-62~specific peptide-induced 
CTL: IC-21 macrophages fed with Ova-containing liposomes (closed 
circles), homologous peptide-pulsed IC-21 cells (large closed 
squares), mock-pulsed IC-21 cells (small closed squares). 
(D) Lysis of IC-21 macrophages by CTL clone 463, same symbols as 
in (C). 
(E) Comparison of proliferation of OVA5562 peptide-induced CTL on 
either the ovalbumin-expressing cell line EG7 or parental EL4 cells. 
The OVA5562 specific peptidainduced long-term CTL line was incu- 
bated (IO cells/well) with irradiated (20,ooO rads) EG7 (closed circles) 
or EL4 (open circles) stimulator cells for 3 days and pulsed during 
the last 15 hr with [3H)thymidine. 
(F) Lysis of OVA55-62-pulsed EL-4 cells by OVA55-62 peptide- 
induced CTL after two rounds of restimulation on the ovalbumin- 
expressing cell EG7. The OVASCBP-specific peptide-induced long 
term CTL line was restimulated twice with the ovalbumin-expressing 
cell EG7. The CTL were tested 5 days after the last restimulation in 
a Wr release assay. Target cells were EL4 cells either untreated 
(open squares), pulsed with OVA5562 (closed squares), or pulsed 
with OVA257-264 (closed triangle). 
of spleen cells from unprimed C57BU6 mice with the syn- 
thetic peptide in the presence of appropriate stimulator 
cell8 (data not shown, see Figure 3). Taken together, there 
is no evidence that the low immunogenicity of Ova%-62 
is caused by a defect in the repertoire of CTL. 
We raised a CTL line from cultures stimulated with 
Ova%-62 by weekly restimulation with peptide-pulsed ir- 
radiated spleen cells. The Kb restriction of this cell line 
was ascertained by using concanavalin A (ConA) blasts 
from a series of MHC congenic and recombinant mice 
(data not shown). This cell line was utilized in furtherexper- 
iments to monitor the presentation of Ova55-62. Peptide 
titrations (data not shown) revealed that the avidity of rec- 
ognition of this cell line was about lo- to 30-fold lower than 
that of the established CTL clone 463 (Walden and Eisen, 
1999) utilized in our experiments to detect the presenta- 
tion of Ova257-264. 
We tested various target cells processing Ova for lysis 
by the Ova55-62-specific CTL line. The data in Figure8 
3A and 3C reveal a small but significant degree of lysis 
of EG7 cells and a marginal degree of lysis of IC-21 macro- 
phages loaded with ovalbumin. The lysis of EG7 cells can 
be somewhat enhanced by interferon? (IFN$, but is con- 
sistently much lower than the lysis of EL-4 and of IC-21 
cells externally pulsed with the Ova55-62 epitope, or the 
lysis of EG7 cells or Ova-loaded IC-21 cells by CTL clone 
4G3, specific for Ova257-264 (Figures 38 and 3D). To- 
gether with the results of Chen et al. (1994) these data 
suggest that presentation of Ova55-62 is detectable on 
target cells processing a large amount of Ova. Additional 
evidence for the presentation of this epitope comes from 
experiments showing that Ova55-62-specific CTL can be 
restimulated with EG7 cells to proliferate (Figures 3E and 
3F). Thus, at the level of Ova present in EG7 cells, the 
degree of presentation of this epitope is insufficient for 
inducing CTL from naive CTL precursors. However, the 
epitope appears to be sufficiently presented for the stimu- 
lation of proliferation and cytolytic activity in activated CTL. 
Influence of Natural Flanking Regions 
on Epitope Presentation 
The subdominant nature of Ova55-62 may be determined 
in part by flanking amino acid sequences. To test this 
possibility, we utilized 22-mer synthetic peptides in which 
the sequences flanking the immunodominant epitope 
Ova257-264 were exchanged against the sequences 
flanking the subdominant epitope Ova55-62(Pcrypl), and 
vice versa (PcrypP). These peptides were compared with 
22-mers synthesized according to the natural sequences 
around both epitopes (POvaY249-269, POvaY47-67; see 
Table 1). Each of the four peptides were loaded into IC-21 
target cells and the generation of both epitopes were moni- 
tored by lysis of the resulting target cells with the specific 
CTL. The results in Figure 4 show that target cells loaded 
with POvaY249-269 were strongly lysed, whereas target 
cells loaded with POvaY47-67 were poorly lysed by CTL 
specific for Ova257-264 or by CTL specific for Ova55-62, 
respectively. Lysisof target cells loaded with POvaY51-71 
by Ova5562-specific CTL was also very inefficient (data 
not shown). Thus, the dominance of Ova257-264.over 
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Figure 4. Exchange of the Flanking Regions of the lmmunodominant 
and the Subdominant Ovalbumin Epitopes in a Reciprocal Fashion 
Suggests that lmmunodominance of OVA257-294 over OVA5562 Is 
Partially Determined by their Flanking Regions 
IC-21 macrophages (1.5 x 103 coincubated with the competitor pep 
tide 04TNP were either mock-pulsed with emptyliposomes(quartered 
squares) or pulsed with liposomes containing synthetic 22-mer pep- 
tides (A), (large closed circles) 10 ug, (small closed circles) 5 ug, POva- 
Y249-299; (large open circles) 10 pg, (small open circles) 5 pg Pcrypl; 
(8). (large closed squares) 10 ug, (small closed squares) 5 pg POva- 
Y47-97; (large open squares) 10 ug, (small open squares)5 ug PcrypP, 
as described in Experimental Procedures Wr-labeled IC-21 were then 
used as targets for lysis by (A), the OVA257-2&l-specific CTL-clone 
4G3, and (B), OVA55-62~specific CTL in a 4 hr 5’Cr release assay. 
The amino acid sequences of the peptides used are given in Table 1. 
Ova%-62 is maintained in target cells independently pro- 
cessing synthetic 22-mer peptides surrounding these epi- 
tapes. Lysis by CTL clone 4G3, recognizing Ova257-264, 
was severely compromised when target cells were loaded 
with Pcrypl instead of POva-Y249-269. Conversely, 
Ova55-62-specific CTL showed better lysis of target cells 
loaded with PcrypP than of target cells loaded with POva- 
Y47-67. These data suggest that immunodominance may 
be determined in part by the nature of the flanking se- 
quences of an epitope. However, the degree of improve- 
ment of presentation of Ova55-62 by the flanking se- 
quences of Ova257-264 was not dramatic, suggesting 
that additional factors may limit the presentation of this 
subdominant epitope. As stated above, these results per 
se do not reveal which level of antigen processing is af- 
fected by flanking regions. 
Determination of Proteasome Cleavage Sites in 
Synthetic 22-mer Peptides Used in thls Study 
We purified 20s proteasomes from the Kb-expressing cell 
line EL-4, using a novel protocol that is simplified as com- 
pared with previous protocols but nevertheless yields 
highly pure proteasomes (Figure 5). The various natural 
and artificial synthetic 22-mer peptides containing 
Ova257-264 and Ova55-62 were coincubated with iso- 
lated 20s proteasomes and the resulting digests were sub- 
jected to pool sequencing. The locations of cleavage sites 
were determined by recording the appearance of unique 
amino acids in sequential Edman degradation; the 
strength of cleavage was estimated from the relative yields 
Figure 5. Polyacrylamide Gel Electrophoresis of Purified Protea- 
somes 
Proteasomes were Isolated from the cytosol of EL-4 cells by fraction- 
ated polyethylene glycol precipitation and anion-exchange chromatog- 
raphy as described in Experimental Procedures. 
(A) SDS-PAGE on a 12% polyacrylamide gel as described by Laemmli 
(1970). The low molecular mass polypeptides between 22-32 kDa 
represent subunits of 205 proteasomes. 
(B) Nondenaturing 5% polyacrylamide gel. Proteins were silver stained 
according to Blum et al. (1997). 
of such amino acids (Figures 6A and 66). The predominant 
cleavage sites in the natural OvaY249-269 sequence 
(POval) after 36 hr were found directly adjacent to the 
N-and C-terminal boundaries of the immunodominant epi- 
tope Ova257-264, although several minor cleavage sites 
were obsenred at other locations in the flanking regions 
and within the epitope (Figure 6A). The cleavage sites 
directly adjacent to the epitope are still detected in POva4, 
but the Pro substitution appears to inhibit proteolyic attack 
in the C-terminal flanking region and to promote cleavage 
within the epitope. POva3 shows virtually abolished cleav- 
age in the Gly-substituted N-terminal flank; nevertheless, 
precise epitope cleavage is maintained to a small degree. 
Peptide POva2 was not at all digested after 36 hr. The 
results after 72 hr of incubation reveal infrequent attack 
at several sites within the epitope, whereas most of the 
22-mer remains undigested. When compared with the 
functional results in Figure 2, we observe an excellent 
correlation between the levels of recognition of Ova257- 
264 upon processing of the four different peptides with 
the efficacies of generation of the epitope suggested by 
proteasomal cleavage (Figure 6A). 
Digestion patterns of OvaY47-67 and of OvaY51-71 
are shown in Figure 6B and reveal that the natural flanking 
regions of the subdominant epitope, Ova55-62, are only 
very inefficiently attacked by proteasomes. No cleavage 
could be detected directly adjacent to the N terminus of 
the epitope and only minor cleavage occurs directly adja- 
cent to the C terminus. Most significantly, the predominant 
cleavage site was found between Arg and Phe within the 
epitope. Predominant cleavage at this site was also de- 
tected in digests shorter than 36 hr (data not shown). In 
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Figure 6. Digestion by 205 Proteasomes of Synthetic 22-mer Peptides Used in this Study 
Synthetic 22-mer peptides were incubated in the presence of purified proteasomes as described in Experimental Procedures. After complete 
consuming of the initial substrate, as monitored by reverse phase HPLC, the digests were subjected to amino acid sequence analysis by Edman 
degradation. Proteasome cleavage sites were determined according to the amounts per sequence cycle of amino acids present only once in the 
polypeptides. The sequences of the substrates are given to the right of the respective panels. Minimal epitopes are underlined. The 20s proteasome 
cleavage sites are indicated by arrows. The size of the arrows reflects the relative usage of the respective cleavage sites. 
(A) The strong signals for N in cycle 4, for K in cycle 7, and for W in cycle 3 indicate that the predominant proteasome cleavage sites in POva-V249- 
269 are the peptide bonds between E-S and L-T, which directly flank the immunodominant epitope 0~257-264. The P-for-T substitution in 
POva4 inhibits proteasomal attack in the C-terminal flanking region (reduced signals for W in cycles 1 and 3) and promotes epitope destruction 
(increased signals of N in cycle 1, of K in cycles 1 and 2, and of W in cycles 5 and 6). The Gly-substituted N-terminal flanking region of POva3 
remains undigested. Some optimal epitope may still be generated as suggested by the signals for N in cycle 4, for K in cycle 7, and for W in cycle 
3. POva2 is largely unattacked in the flanking regions even after 72 hr of digestion. Most of the substrate remains undigested. 
(B) In POva-V47-67 and POva-V51-71, minor cleavage sites are located between I-N (N in cycle 1 and R in cycle 5) and L-P (P in cycle 1 and 
E in cycle 6) in the N- and C-terminal flanking regions of Ova55-62, respectively. The strong signals for P in cycle 5 and for E in cycle 12 show 
that most of the subdominant epitope is destroyed by the trypsin-like cleavage site between R and F. In Pcrypl. only minor cleavage occurs in 
the flanking regions (E detected in cycle 7 and P in cycle 1). whereas the immunodominant epitope is now preferentially destroyed between 
F-E and E-K (E in cycle 1, P in cycles 3 and 4). In PcrypP, the subdominant epitope is still attacked at several sites (F in cycles 1 and 2 and W 
in cycles 4-6) but the major cleavage site is now located between L and E in the N-terminal flanking region (F in cycle 6 and W in 12). Also, the 
N-terminal epitope boundary (E-K) is used (F in cycle 5). 
addition, we have studied a 30-mer (Ova42-71) and found Similarly intriguing results are obtained with peptides 
a similar cleavage pattern around and within the epitope Pcrypl and Pcryp2, also shown in Figure 6B. The flanking 
(data not shown). Thus, while the immunodominant epi- sequences of Ova55-62 confer the cleavage characteris- 
tope is efficiently and precisely cleaved from its sur- tics of the subdominant epitope to the dominant one. The 
rounding sequences, the subdominant epitope is ineffi- main cleavage site in Pcrypl lies now within the epitope; 
ciently cleaved from its flanking sequences and, for the the flanking regions are only inefficiently attacked and the 
most part, destroyed by proteolytic attack within the epitope. N-terminal cleavage site is apparently lost. Pcryp2, in con- 
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trast, does not fully adopt the cleavage characteristics of 
the dominant epitope. The predominant cleavage site is 
now outside the epitope; Ova55-62 may now be precisely 
cut out to some extent, but several minor internal sites 
are generated so that much of the epitope continues to 
be destroyed. Again, these data are in striking correlation 
with the results on in vivo processing of these peptides 
as shown in Figure 4. 
For CD4+ T cell responses, hierarchies among MHC class 
II-restricted determinants of protein antigens have been 
extensively documented (for review see Sercarz et al., 
1993). Recently, evidence has accumulated that similar 
hierarchies exist among MHC class l-restricted epitopes. 
The aim of this study was to analyze whether such hierar- 
chies would in part be determined by proteolytic cleavage 
of antigens, in particular by proteasomes. If proteolysis 
were a limiting factor in the generation of MHC class I 
epitopes, not only the sequence of the epitope itself but 
also the flanking sequences should be of importance. The 
influence of flanking regions in antigen processing has 
so far been controversial. Chimini et al. (1969) inserted a 
sequence encoding a 13-mer antigenic peptide into an 
unrelated foreign gene and Hahn et al. (1991) inserted a 
20-mer influenza haemagglutinin (HA) sequence con- 
taining two overlapping epitopes into several different po- 
sitions of the influenza nucleoprotein gene. In both stud- 
ies, the epitopes were generated from the recombined 
sequences as efficiently as they were from the natural 
sequences. Hahn et al. (1992) also tested about 60 in- 
duced mutations in the region of the two overlapping CTL 
epitopes of influenza HA; only one of the mutations in 
the flanking regions compromised epitope generation. In 
contrast, Del Val et al. (1991) inserted the minimal epitope 
of the cytomegalovirus immediate-early antigen into two 
different sites of an unrelated carrier gene and found pro- 
nounced differences in the generation of the epitope de- 
pendent on its position in the recombinant sequence. Data 
supporting a role for residues flanking an epitope were 
also reported by Eisenlohr et al. (1992a). Taken together, 
the role of flanking regions for the generation of epitopes 
appears incompletely understood and warrants additional 
investigation. 
To this end, we developed a system to load synthetic 
peptides into the class I presentation pathway of target 
cells by the use of pH-sensitive liposomes. Although puta- 
tive differences in the interaction of peptides with lipids 
may influence peptide loading, the major advantage of 
this system over approaches using transfection of genes 
or infection with recombinant viruses is the possibility to 
control better the amounts of antigen loaded into the cells. 
A caviat associated with this system may be that intact 
22-mer peptides or slightly shorter peptides possibly con- 
taminating our 22-mers at subdetectable level may get 
transported into the ER and presented without the need 
for processing. However, recent studies have shown that 
the preferred length for TAP-mediated peptide transport 
is 7-l 3 aa and longer peptides are poorly transported, if 
at all (Heemels and Ploegh, 1994; Momburg et al., 1994b). 
Using this system, we investigated influencesof variations 
in the flanking regions on the generation of two w-restricted 
epitopes of chicken Ova by in vivo processing of synthetic 
22-mer peptides containing these epitopes. These func- 
tional data were compared with biochemical results ob- 
tained by in vitro digestion of the same peptides by isolated 
proteasomes. Weobsenre a profound influence of flanking 
regions in both assays and a striking correlation between 
the efficacy and pattern of proteasomal cleavage in vitro 
and the generation of an epitope by processing in vivo. 
We first investigated the effects of substituting selected 
amino acid residues on either side of the immunodominant 
epitope Ova257-264. We find that these substitutions af- 
fect the generation of the epitops both by antigen pro- 
cessing in vivo and by proteasomal cleavage in vitro, to 
varying degrees. Ova257-264 is efficiently and precisely 
cleaved from the synthetic 22-mer POvaY249-269, corre- 
sponding to the natural sequence. This correlates well with 
the efficient sensitization of target cells loaded with this 
peptide. Substitutions of acidic and hydrophobic residues 
by Gly in both flanks virtually abrogates both the genera- 
tion of the epitope in vivo and proteasomal cleavage in 
vitro. These results seem to be at variance with recent 
observations that proteasomes have a proteolytic compo- 
nent cleaving peptide bonds between small neutral amino 
acids. However, both Gly-Gly and Ala-Gly bonds were 
found to be cleaved with relatively low specific activity and 
only in special synthetic peptide substrates having a Pro 
residue in the P3 position (Orlowski et al., 1993). The data 
are consistent with the proteolytic specificities of protea- 
somes that efficiently cleave on the carboxyl side of acidic 
and hydrophobic amino acid residues. The less dramatic 
impairment caused by a Pro directly C terminal to the epi- 
tope is consistent with the fact that peptide bonds involving 
Pro are relatively resistent to endo- and exopeptidases 
with broader substrate specificity (Demuth et al., 1993). 
This may also be the case for proteasomes, as suggested 
by the results shown in Figures 6Aand 66. Taken together, 
the data on artificially altered sequences surrounding the 
immunodominant epitope, Ova257-264, are consistent 
with the notion that the generation of this epitope is related 
to the relative sensitivity of the flanking sequences to pro- 
teasomal digestion. 
CTLs specific for Ova55-62 are normally not detected 
in mice immunized with Ova. Chen et al. (1994) have ex- 
plained the poor immunogenicity of Ova55-62 in the im- 
mune response to Ova by the approximately 50-fold lower 
Kb binding affinity compared with Ova257-264. In com- 
menting on these results, Barber and Parham (1994) have 
pointed out that peptide generation as well as a host of 
additional factors may determine the immunogenicity of 
epitopes. Along the same line, other experiments (Jame- 
son and Bevan, 1992; Lipford et al., 1993) suggest a 
merely 5- to lo-fold difference in Kb binding between 
Ova257-264 and Ova55-62. Moreover, Oval 76-l 63 has 
significant immunogenicity (Lipford et al., 1993), even 
though its Kb binding affinity was found by Lipford et al. 
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(1993) to be comparable to and by Jameson and Bevan 
(1992) to be approximately lo-fold lower than that of 
Ova55-62. 
The C terminus of Ova55-62 is directly flanked by a 
Pro, indicating the possibility that it may be inefficiently 
presented because of inefficient proteolytic processing. 
We found strong support for this hypothesis in our experi- 
ments in which the flanking regions of Ova257-264 and 
Ova55-62 were reciprocally exchanged, resulting in pep- 
tides Pcrypl and PcrypP, respectively. Using pool se- 
quencing by Edman degradation of proteasomal digests 
of two different synthetic 22-mers and one 30-mer corre- 
sponding to natural Ovasequences, we found no evidence 
for precise and efficient cleavage of Ova55-62. Instead, 
we consistently found a major cleavage site within the 
sequence of this epitope so that most of it is expected to 
be destroyed by proteasomal digestion. Thus, the pro- 
cessing of Ova55-62 appears to be limited by both in- 
efficient proteolytic attack in the flanking sequences and 
destruction of the epitope itself. Our functional and bio- 
chemical results on the peptide Pcrypl suggest that the 
cleavage pattern including digestion within the epitope it- 
self may be strongly influenced by the flanking regions. 
However, the improvement in the generation of the sub- 
dominant epitope from peptide Pcryp2 wasonly moderate, 
by either biochemical or functional analyses. Thus, the 
sequence of the epitope itself as well as the surrounding 
sequences restrict its generation by proteolysis. Dick et 
al. (1994) have detected Ova257-264 but not Ova55-62 
in digests of intact Ova. We have also subjected denatured 
intact Ova to digestion by proteasomes and found that 
target cells sensitized with the digest were much more 
sensitive to lysis by Ova257-264-specific CTL than by 
Ova55-62-specific CTL (data not shown). While this latter 
experiment remains inconclusive for several reasons, it 
further emphasizes the striking correlation between pro- 
teasomal cleavage and presentation of the two epitopes 
under study. This suggests that proteasomes have an 
important role in determining immunodominance of 
Ova257-264 over Ova55-62. 
Considering the destruction of most of the epitope 
Ova55-62 by proteasomal cleavage, it is intriguing that 
we find clear evidence for the recognition of this epitope on 
the cell surface. Although no evidence for the generation of 
the minimal epitope upon proteasomal cleavage is ob- 
served, the results suggest that small amounts of longer 
antigenic peptides containing the epitope are generated 
by proteasomes. This is consistent with the small increase 
of the signals for Leu in sequence cycle 9 and for Pro in 
cycle 10 of Edman degradation of the digests of OvaY47- 
67 and OvaY51-71 (see Figure 6B). Preliminary results 
from direct sequencing of individual peptides isolated by 
reverse phase high performance liquid chromatography 
(HPLC) from proteasome digests show the generation of 
Small quantities of a peptide Ova54-63, i.e., slightly larger 
than the optimal peptide Ova55-62. It is possible that such 
slightly longer peptides are generated and bind to the Kb 
molecule as such or may be further trimmed by exopepti- 
dases. The latter possibility has been demonstrated in a 
model experiment but so far has not been directly shown 
to occur in vivo (Eisenlohr et al., 1992b). In addition, we 
have preliminary evidence from analyses of digests by 
mass spectrometry that the minimal epitope is generated 
by proteasomes in trace amounts, perhaps sufficient for 
low level presentation (G. N. et al., unpublished data). 
In the EG7 cell line, the subdominant epitope Ova55- 
62 is presented to an extent that is insufficient for the 
stimulation of naive CTL precursors but sufficient to re- 
stimulate activated CTL, either to proliferate or for target 
cell killing. Data by Nonacs et al. (1992) suggest that the 
concentration of peptide required bydendritic cells for acti- 
vation of naive CTL is about 1000 times greater than that 
required to sensitize target cells for lysis by activated CTL. 
Subdominant epitopes of this type may be of interest in 
vaccine development, on the one hand, as well as for pos- 
sible mechanisms of autoimmunity, on the other hand. In 
a primary infection or in immunity to tumors, CTLs against 
subdominant epitopesare usually not generated. As acon- 
sequence, there is no natural immunoselection by recogni- 
tion of subdominant epitopes that may therefore often be 
associated with proteins essential to the survival of the 
infectious agent orthe tumor. This is in contrast with immu- 
nodominant epitopes, which, in most cases, can be ex- 
pected to be associated with proteins of minor importance 
to the survival of the infectious agent or the tumor. Thus, 
subdominant epitopes may be particularly promising as 
targets of vaccination against infections and against tu- 
mors. According to the same principle, subdominant epi- 
topes may contribute to autoimmunity. Epitopes of envi- 
ronmental antigens mimicking a subdominant self-epitope 
may activate a naive CTL population which, as memory 
cells, can be restimulated by the endogeneous subdomi- 
nant epitope, thus giving rise to autoimmunity. Taken to- 
gether, the results presented in this paper may not only 
augment our understanding of the mechanisms involved 
in antigen processing, but may also shed light on immuno- 
logical disorders and help in the design of vaccination pro- 
tocols. 
Experimental Procedures 
Synthetic Peptides 
Peptides were synthesized on a Zinsser Analytic SMPS 350 A multiple 
peptide synthesizer or on an automatic synthesizer (Model 431A, Ap- 
plied Biosystems, Foster City, California), and subsequently purified 
by reverse phase HPLC. Peptide purity was controlled by analytical 
reverse phase HPLC and ion-spray mass spectrometry (Sciex API III, 
TAGA). 
Animals, Cells, and Culture Conditions 
C57BU6 (H-2Kb, Db) mice were from our specific pathogen-free breed- 
ing facility. CTL clone 4G3 (Walden and Eisen, 1990), specific for the 
chicken ovalbumin peptide 257-264 in association with Kb (Rdlzschke 
et al., 1991), and EG7 cells, produced by transfecting the C57BU 
s-derived thymoma EL-4 with the chicken ovalbumin gene (Moore et 
al., 1999), were provided by P. Walden (Max Planck lnstitut fiir Biolo- 
gie, Tcbingen, Federal Republic of Germany). RMA and RMA-S cells 
(Ljunggren and Karre. 1965; tirre et al., 1986) were obtained from 
K. KLrre (Stockholm). The macrophage line IC-21 and EL4 cells were 
purchased from American Type Culture Collection (Rockville, Mary- 
land). RMA, RMA-S and EL-4 cells were cultivated in RPM medium 
supplemented with 10% fetal calf serum, B-mercaptoethanol, ~gluta- 
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mine, and antibiotics. Culture medium for CTLs was supplemented 
RPM medium containing 2.5 mM HEPES. IC-21 macrophages were 
propagated in Iscove’s medium supplemented with 10% fetal calf se- 
rum, L-glutamine, and antibiotics. 
In Vitro Induction of CTL 
OVA6562 peptidespecific CTL were generated by cocultivating 4 x 
10’ naive C57BU6 responder spleen cells and 4 x lo5 irradiated stimu- 
lator cells @MA-S and syngeneic spleen cells, 3:l) in 0.2 ml RPM 
containing 10% ConA-induced rat spleen cell supernatant supple- 
mented with 50 mM a-methyl mannoside and 2.5 uglml of peptide in 
96well round-bottomed microtiter plates. An OVA5C62specific CTL 
line was maintained by weekly restimulation with C57BU6 spleen cells 
in the presence of 2.5 pg/ml OVA5662 peptide. 
Liposome Preparation 
The following lipid preparations were used: dioleoyl phosphatidyletha- 
nolamine (DOPE) and 1,2dioleoyl-sn-3succinylglycerol (DOSG) from 
Avanti Polar Lipids (Birmingham, Alabama), cholesterol (Chol) from 
ICN Pharmaceuticals (Plainview. New York), and egg phosphatidyl- 
choline (PC) from Kharkov Bacterial Preparations Company (Kharkov, 
Ukraine). Liposomes were prepared according to the procedure de- 
scribed by Zhou et al. (1991). Small unilamellar vesicles from equimo- 
lar amounts of DOPE-DOSG (pH sensitive) or a 3:l molar ratio of PC- 
Chol (pH insensitive) were prepared by ultrasonication. Cvalbumin 
(5 mg) (grade VI, Sigma, St. Louis, Missouri), 7.5 mg FITC-dextran 
(MW 20.000, Sigma), or different amounts of peptide in 50 ul phos- 
phate-buffered saline (PBS) (pH 6.0) were added to the small unilamel- 
lar vesicle suspension in 310 ul PBS and the mixtures were subjected 
to three freeze-thaw cycles. Prior to use, the freeze-thaw liposomes 
were pelleted by centrifugation for 30 min at 100,060 x g and washed 
to remove unencapsulated material. The amount of entrapped peptide 
was determined using a modified Micro-Lowry assay as described 
(Niedermann et al., 1991). 
Confocrl Laser Scanning Microscopy 
Macrophages (5 x 10’) were plated in Permanox chamber slights 
(Nunc, Incorporated, Napewille, Illinois) and grown overnight. Before 
adding liposomes, growth medium was replaced by 300 ul PBS con- 
taining 0.4 mM CaCb, 0.4 mM MgCb, and 5 mM D-ghJWSe. FITC- 
dextran-loaded liposomes (20 pl containing 5 nmol liposomal phospho- 
lipid) were added and the cultures incubated for 30 min at 37OC in an 
atmosphere containing 5% CO?. Cells were washed several times with 
PBS and were further incubated for 1 hr with growth medium until 
examination using an inverted Leitz confocal laser scanning micro- 
scope (LEICA, Heidelberg, Federal Republic of Germany). An argon 
laser (wavelength, 466 nm) was used to excite FITC. Optical sections 
were taken at 0.5 urn intervals between the apical and basal poles 
through the entire cells. 
Cytotoxlc T Lymphocyte Assays and Target Cell Preparation 
RMA, EL-4, IC-21 cells, or 46 hr ConA-activated spleen cells served 
as targets in standard 4 hr 5’Cr release assays. Target cells were 
labeled with 100 uCi 5’Cr (New England Nuclear Research Products, 
Boston, Massachusetts) for 90 min at 37OC and washed twice with 
RPMI. Labeled target cells were then sensitized for CTL-mediated 
lysis by preincubation with synthetic peptides or a proteasome digest 
of ovalbumin for 2 hr at room temperature, washed, and added to 
effector cells. 
Incubation of IC-21 macrophages with peptide-containing lipo- 
somes was performed prior to chromium labeling: 1.5 x lo6 cells 
in 3.5 ml of protein-free Iscove’s medium were pulsed with peptide- 
liposomes (or with free peptides for control, freeze-thawed as the 
liposome preparations) for 90 min at 37OC in 5% CO*, washed twice, 
incubated for additional 30 min in complete Iscove’s medium, and then 
labeled with “‘Cr. The competitor peptide was present 30 min prior to 
the addition of liposomes at a concentration of 16’ M throughout 
incubation with the liposomes and was maintained at 10e5 M until the 
end of the 5’Cr release assay. 
Prollferatlon Assay 
Proliferation of the Cva55-62epecific CTL line was assessed in 96 
well plates in triplicate cultures of 0.2 ml volume by stimulation of 10’ 
CTL with graded numbers of irradiated (20,000 rads) EG7 or EL4 cells 
for 3 days. DNA synthesis was determined by PH)thymidine uptake 
during the last 15 hr of culture. 
Isolation of Proteasomes from Cultured Cells 
EL4 cells were grown in roller bottle cultures to a density of about 1 x 
l@ cells/ml. About 2 x loo cells were washed twice with cold PBS, 
resuspended in 100 ml imidazole buffer (20 mM imidazole-HCI [pH 
6.61, 100 mM KCI, 20 mM EGTA. 2 mM MgC&, 10% sucrose) and 
were then subjected to N1 cavitation. The resulting suspension was 
subsequently centrifuged (15 min at 1,500 x g, 15 min at 15,000 x 
g, 90 min at 150,000 x g). Aliquots (10 ml) of the supernatant obtained 
after the last centrifugation step were supplemented with polyethylene 
glycol 6000 to a final concentration of 5% (w/v). After incubation for 
30 min at 4°C. precipitated material was removed by centrifugation at 
20000 x g. The supernatant was adjusted to 12.5 % (w/v) polyethylene 
glycol6000, centrifuged, and the resulting pellet dissolved in 2 ml cold 
Tris buffer (50 mM Tris-HCI [pH 7.21, 1 mM EGTA, 5 mM MgCI,. 0.5 
mM 6-mercaptoethanol). The resuspended material was applied to a 
Mono Q (HR515) column (Pharmacia, Uppsala, Sweden) attached to 
a Waters HPLC system (Waters, Division of Millipore, Milford, Massa- 
chusetts). Bound proteins were eluted with a NaCl gradient; buffer A 
(20 mM Tris-HCI [pH 7.21) buffer B (20 mM Tris-HCI [pH 7.21, 1 M 
NaCI); O-1 0 min at 106% for buffer A; 10-65 min with a linear increase 
to 34% for buffer B; 65-95 min with a linear increase to 36% for buffer 
B (flow rate: 0.5 mUmin), 95-105 min with a linear increase to 100% 
for buffer B (flow rate: 1 mllmin). Size of collected fractions, 0.5 ml. 
Proteasome peptidase activity was determined fluorimetricatly using 
the substrate Sue-LLW-MCA as described (McGuire and Martino, 
1966). Column fractions containing activity (at about 35% B) were 
pooled and the proteasome purity assessed electrophoretically. Poly- 
acrylamide gel electrophoresis in the presence of sodium dodecylsul- 
fate was essentially performed by the method of Laemmli (1970) in 
12% slab gels and native polyacrylamide gel electrophoresis was done 
in 5% slab gels. Proteins were detected by silver staining as described 
(Blum et al., 1967). 
Protrasome Dlgestlon of Synthetic Polypeptldes 
Digestions of synthetic peptides (20 pg) with 0.5 ug isolated protea- 
somes were performed in a final volume of 300 ul Tris buffer (50 mM 
Tris-HCI [pH 7.61, 1 mM EGTA, 2 mM MgCI,, 0.5 mM 6-mercap- 
toethanol) for 36 hr at 37OC. To assess cleavage of synthetic peptides, 
30 ul of digest were separated by reverse phase HPLC (Sephasil Cl6 
2.1110, SMART system, Pharmacia, Uppsala, Sweden). The applied 
material was eluted with a flow rate of 106 ullmin with an acetonitrile 
gradient: solution A, 0.1% (v/v) trifluoroacetic acid (TFA); solution B, 
0.061% (v/v) TFA in 60% acetonitrile-H20; O-10 min at 0% for solution 
B, 10-40 min with a linear increase to 75% for solution B. Sequencing 
of the peptide mixtures employed Edman degradation on a Hewlett 
Packard instrument (Model HP1 005A, Scientific Instruments Division, 
Palo Alto, California). For determination of proteasome cleavage sites, 
data obtained from Edman sequencing were evaluated as described 
(Bees et al., 1994). 
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